Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
9.78
-0.24 (-2.40%)
At close: Dec 5, 2025, 4:00 PM EST
9.83
+0.05 (0.51%)
After-hours: Dec 5, 2025, 7:25 PM EST
Delcath Systems Employees
Delcath Systems had 96 employees as of December 31, 2024. The number of employees increased by 20 or 26.32% compared to the previous year.
Employees
96
Change (1Y)
20
Growth (1Y)
26.32%
Revenue / Employee
$829,198
Profits / Employee
$12,479
Market Cap
345.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DCTH News
- 3 days ago - Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma - Business Wire
- 16 days ago - Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program - Business Wire
- 18 days ago - Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma - Business Wire
- 22 days ago - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 23 days ago - Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients - Business Wire
- 4 weeks ago - Delcath Systems to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Delcath: Temporary Headwinds Are No Cause For Concern - Seeking Alpha
- 4 weeks ago - Delcath Systems, Inc. (DCTH) Q3 2025 Earnings Call Transcript - Seeking Alpha